MORGAN STANLEY

Holdings History for Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Symbol: CMMB on Nasdaq
Investment type: Equity / Ordinary Shares / American Depositary Shares
Latest Disclosed Shares Owned: 13,213,260 shares
Security Ownership %: 3.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB)

07 Aug 2025 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,213,260 shares of Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB). This represents 3.2% ownership of the company. This is the first filing by MORGAN STANLEY disclosing ownership of Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Morgan Stanley	3.2%		$16,120,177	13,213,260			$1.22	13G/A	31 Jul 2025	07 Aug 2025, 16:21
Morgan Stanley	8.4%		$39,384,870	32,282,680			$1.22	13G	30 Jun 2025	07 Aug 2025, 11:45

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-1,614,134	-100%		Q3 2025
30 Jun 2025	0%	+0%	$1,872,395	1,614,134	+1,496,974	+1278%	$1.16	Q2 2025
31 Mar 2025	0%	+0%	$127,704	117,160	+12,760		$1.09	Q1 2025
31 Dec 2024	0%	-0%	$188,964	104,400	-297,872		$1.81	Q4 2024
30 Sep 2024	0%	+0%	$631,567	402,272	+395,072	+5400%	$1.57	Q3 2024
30 Jun 2024	0%	0%	$6,570	7,200	+4,403	+100%	$0.9125	Q2 2024
31 Mar 2024	0%	0%	$2,179	2,797	0		$0.7790	Q1 2024
31 Dec 2023	0%	0%	$36,167	70,915	0		$0.5100	Q4 2023
30 Sep 2023		0%	$0	0	-100	-100%		Q3 2023
30 Jun 2023	0%	-0%	$132	100	-7,700	-99%	$1.32	Q2 2023
31 Mar 2023	0%	0%	$12,402	7,800	+1,200	+18%	$1.59	Q1 2023
31 Dec 2022	0%	0%	$21,120	6,600	+400	+6.5%	$3.20	Q4 2022
30 Sep 2022	0%	0%	$15,000	6,200	+605	+11%	$2.42	Q3 2022
30 Jun 2022	0%	+0%	$21,000	5,595	+5,595	NEW	$3.75	Q2 2022
31 Mar 2022		-0%	$0	0	-11,643	-100%		Q1 2022
31 Dec 2021	0%	+0%	$80,000	11,643	+11,548	+12156%	$6.87	Q4 2021
30 Sep 2021	0%	0%	$1,000	95	-68	-42%	$10.53	Q3 2021
30 Jun 2021	0%	0%	$3,000	163	-171	-51%	$18.40	Q2 2021
31 Mar 2021	0%	+0%	$10,000	334	+334	NEW	$29.94	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.